Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Pretreatment of Low-Dose Decitabine to Leukemia Cells Markedly Enhances the Cytotoxicity of Gemtuzumab Ozogamicin

Miwa Kurimoto, MD, Hiroshi Matsuoka, MD, PhD, Nobuyoshi Hanaoka, MD, PhD, Shima Uneda, MD, PhD, Takashi Sonoki, MD, PhD, Hideki Nakakuma, MD, PhD

Blood (2011) 118 (21): 5000.

https://doi.org/10.1182/blood.V118.21.5000.5000

Published: 2011

Journal Articles

NKG2D-Mediated Marrow Injury in Paroxysmal Nocturnal Hemoglobinuria and Its Related Disorders.

Nobuyoshi Hanaoka, MD, PhD, Tatsuya Kawaguchi, MD, PhD, Kentaro Horikawa, MD, PhD, Shoichi Nagakura, MD, PhD, Sonoko Ishihara, MD, PhD, Yasuchika Tsuzuki, MD, Yuji Yonemura, MD, PhD, Hideki Nakakuma, MD, PhD

Blood (2007) 110 (11): 3674.

https://doi.org/10.1182/blood.V110.11.3674.3674

Published: 2007

Journal Articles

ULBP and MICA/B as Novel Indicators for Both Diagnosis of Immune-Mediated Marrow Injury and Favorable Response to Immunosuppressive Therapy in Bone Marrow Failure Syndromes.

Nobuyoshi Hanaoka, MD, PhD, Tatsuya Kawaguchi, MD, PhD, Kentaro Horikawa, MD, PhD, Shoichi Nagakura, MD, PhD, Yasuchika Tsuzuki, MD, Yuji Yonemura, MD, PhD, Hideki Nakakuma, MD, PhD

Blood (2006) 108 (11): 990.

https://doi.org/10.1182/blood.V108.11.990.990

Published: 2006

Journal Articles

Appearance of Stress-Inducible Membrane Proteins ULBP on Blood Cells of Patients with PNH, Aplastic Anemia, and MDS: Possible Implication of ULBP in Immune-Mediated Marrow Injury.

Nobuyoshi Hanaoka, MD, Kentaro Horikawa, MD, PhD, Yasuchika Tsuzuki, MD, Shoichi Nagakura, MD, PhD, Sonoko Ishihara, MD, PhD, Hiroaki Mitsuya, MD, PhD, Hideki Nakakuma, MD, PhD, Tatsuya Kawaguchi, MD, PhD

Blood (2005) 106 (11): 1041.

https://doi.org/10.1182/blood.V106.11.1041.1041

Published: 2005

Journal Articles

Decrease in Sensitivity of PIG-A -Mutant Cells to Natural Killer Cells Conferred by Missing of Stress-Inducible Membrane Proteins ULBPs.

Nobuyoshi Hanaoka, MD, Tatsuya Kawaguchi, MD, PhD, Kentaro Horikawa, MD, PhD, Shoichi Nagakura, MD, PhD, Sonoko Ishihara, MD, PhD, Hiroaki Mitsuya, MD, PhD, Hideki Nakakuma, MD, PhD

Blood (2004) 104 (11): 2829.

https://doi.org/10.1182/blood.V104.11.2829.2829

Published: 2004

NARROW

Pretreatment of Low-Dose Decitabine to Leukemia Cells Markedly Enhances the Cytotoxicity of Gemtuzumab Ozogamicin

NKG2D-Mediated Marrow Injury in Paroxysmal Nocturnal Hemoglobinuria and Its Related Disorders.

ULBP and MICA/B as Novel Indicators for Both Diagnosis of Immune-Mediated Marrow Injury and Favorable Response to Immunosuppressive Therapy in Bone Marrow Failure Syndromes.

Appearance of Stress-Inducible Membrane Proteins ULBP on Blood Cells of Patients with PNH, Aplastic Anemia, and MDS: Possible Implication of ULBP in Immune-Mediated Marrow Injury.

Decrease in Sensitivity of PIG-A -Mutant Cells to Natural Killer Cells Conferred by Missing of Stress-Inducible Membrane Proteins ULBPs.

Email alerts

ASH Publications

American Society of Hematology

Pretreatment of Low-Dose Decitabine to Leukemia Cells Markedly Enhances the Cytotoxicity of Gemtuzumab Ozogamicin

NKG2D-Mediated Marrow Injury in Paroxysmal Nocturnal Hemoglobinuria and Its Related Disorders.

ULBP and MICA/B as Novel Indicators for Both Diagnosis of Immune-Mediated Marrow Injury and Favorable Response to Immunosuppressive Therapy in Bone Marrow Failure Syndromes.

Appearance of Stress-Inducible Membrane Proteins ULBP on Blood Cells of Patients with PNH, Aplastic Anemia, and MDS: Possible Implication of ULBP in Immune-Mediated Marrow Injury.

Decrease in Sensitivity of PIG-A -Mutant Cells to Natural Killer Cells Conferred by Missing of Stress-Inducible Membrane Proteins ULBPs.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only